The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...

An endocrinologist reveals the one mistake that can wreck your hard-earned results after stopping GLP-1 weight-loss meds.

Influencer Nabela Noor shared a video exploring her personal style this holiday season following a 60-pound weight loss.

Since 2007, Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.

Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

A notable finding is that audiences are split on whether they see more pharma ads in 2025 compared to 2024. Nearly half of ...

Caprice opens up to Closer’s Neeru Sharma about her lavish Christmas, her ordeal with weight-loss injections, and her ...

Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...

A federal judicial panel on Monday ordered that a growing number of lawsuits accusing Novo Nordisk and Eli Lilly of causing ...

Becton Dickinson and Co, iShares U.S. Pharmaceuticals ETF, BlackRock Health Sciences Trust. Read 's Market Analysis on Investing.com ...